Symbol="MRKR"
AssetType="Common Stock"
Name="Marker Therapeutics Inc"
Description="Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas."
CIK="1094038"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="50 N LAURA STREET, SUITE 2500, JACKSONVILLE, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="57808000"
EBITDA="-24194024"
PERatio="None"
PEGRatio="None"
BookValue="2.163"
DividendPerShare="0"
DividendYield="0"
EPS="-2.88"
RevenuePerShareTTM="1.081"
ProfitMargin="-1.429"
OperatingMarginTTM="-2.967"
ReturnOnAssetsTTM="-0.462"
ReturnOnEquityTTM="-1.158"
RevenueTTM="9255700"
GrossProfitTTM="-17125779"
DilutedEPSTTM="-2.88"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.035"
AnalystTargetPrice="40"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.593"
PriceToBookRatio="1.134"
EVToRevenue="3.641"
EVToEBITDA="-0.472"
Beta="1.219"
num_52WeekHigh="9.68"
num_52WeekLow="0.671"
num_50DayMovingAverage="4.907"
num_200DayMovingAverage="2.921"
SharesOutstanding="8798800"
DividendDate="2016-09-16"
ExDividendDate="None"
symbol="MRKR"
open="6.64"
high="6.95"
low="6.50"
price="6.56"
volume="36619.00"
latest_trading_day="2023-08-22"
previous_close="6.50"
change="0.06"
change_percent="0.9231%"
aroon_positive_momentum_days="53"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="606161"
Change_recent_avg="0.05"
Delta_recent_avg="0.47"
Variance_recent_avg="0.23"
Change_ratio_recent_avg="1.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="161"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="560"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_positive_thumbnail_id_1="675"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_positive_thumbnail_id_2="606"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
